Trial Profile
Cohort Study of Pioglitazone and Cancer Incidence in Patients With Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Mar 2018
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Takeda
- 11 Nov 2016 New trial record